TFF Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TFF Pharmaceuticals, Inc. - overview
Established
2018
Location
Austin, TX, US
Primary Industry
Pharmaceuticals
About
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company specializing in advanced drug delivery systems that enhance therapeutic efficacy through innovative technologies like Thin Film Freezing. Founded in 2018 in Austin, US, TFF Pharmaceuticals, Inc. focuses on transforming liquid medications into powdered forms suitable for inhalation.
The company has successfully raised a total of USD 25. 90 mn through a recent Private Placement/Follow on round in August 2020. TFF Pharmaceuticals has an effective presence with a total of 4 deals recorded, the latest being in October 2019, when they raised USD 22. 00 mn in an IPO.
The founder's previous ventures, if available, were not disclosed. TFF Pharmaceuticals is focused on innovative drug delivery systems that improve the efficacy of existing drugs. Its patented Thin Film Freezing (TFF) technology converts liquid drug formulations into inhalable powdered forms, significantly improving medication bioavailability. The company primarily caters to pharmaceutical partners seeking advanced delivery solutions, while the end users are patients needing effective inhalation therapies.
The main markets targeted by TFF Pharmaceuticals include North America and Europe, leveraging a demand for biopharmaceutical innovations. In the most recent fiscal year, 2023, TFF Pharmaceuticals reported a revenue of USD 733,871 with an EBITDA of USD -21,392,182. The company's revenue model relies on partnerships with pharmaceutical companies, significantly through licensing its proprietary technology and receiving milestone payments for development progress, further aligning with royalty structures on commercialized products. TFF Pharmaceuticals aims to enhance its offerings by advancing its research and development programs, utilizing funding from its latest deal to support these initiatives.
The company plans to develop and release new products targeting specific therapeutic areas, with precise timelines yet to be established. Additionally, TFF Pharmaceuticals is looking to expand into new markets within Europe and North America by leveraging its innovative drug delivery systems. The funding raised in August 2020, amounting to USD 25. 90 mn, will play a crucial role in driving these growth strategies forward.
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.tffpharma.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
TFF Pharmaceuticals, Inc. - timeline of key events
TFF Pharmaceuticals, Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - |
| EBITDA (USD) | (3,898,146) | (11,987,557) | (18,693,650) | - | - | - |
| Operating Income (USD) | (3,898,146) | (11,987,557) | (18,693,650) | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - |
| NET Income (USD) | 3,842,186 | (11,870,228) | (18,567,234) | - | - | - |
| % Net Margin | - | - | - | - | - | - |
TFF Pharmaceuticals, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.